A remedy for alcohol addiction
Israel’s Clearmind Medicine has been granted permission to begin trials at Sheba Medical Center of MEAI (5-methoxy-2-aminoindane) - a synthetic compound developed in Canada to treat alcoholics. Clearmind spent years making the MEAI-based oral capsules conform to medical standards.
Weighty cancer discovery
Researchers at Israel’s Weizmann Institute have analyzed the build-up of ammonia that impairs immune cells in 50% of cancer patients. It blocks the protein regulator HNF4-alpha, causing weight loss and tumor growth. In lab tests, restoring HNF4-alpha production stops weight loss and shrinks the tumors.
Successful skin cancer treatment
A small trial of Alpha DaRT from Israel’s Alpha Tau (see previously) was 100% successful in treating 10 patients with skin cancer. All were 100% clear at 12 weeks with no recurrence or toxicities in 24 weeks.
Hospital testing goes virtual
Israel’s Sheba Medical Center has partnered with Israel’s Mpcheck and Israel’s Teva to allow Teva’s employees to perform medical tests at their workplace or at home. Sheba Virtual Hospital’s "Beyond" tests include blood, urine, cervical cancer, hearing and more.
Speak to an AI expert anytime
Israel’s Wolfson Medical Center in Holon is using artificial intelligence to monitor female cancer patients undergoing chemotherapy in partnership with Israel’s XOLTAR ai. Patients receive personal, round-the-clock support tailored to their individual needs based on AI analyzed data.
Biomed Israel 2023
One of the sessions at Biomed 2023 is personal nutrition. It is a field of technology based on multidisciplinary research that utilizes AI and machine learning to tailor unique nutrition recommendations.
One number to call them all
Israel is to unify the emergency medical hotline number. Currently, each medical emergency service has its own number – 101 for Magen David Adom, 1221 for United Hatzalah etc. Subject to Knesset approval, the public will just call 101, which all services can respond to.
Where does creativity come from
A study at Israel’s Beilinson hospital is looking at why many Parkinson’s patients develop an obsessive desire to take up art or creative writing for the first time. Researchers are investigating if the area of the brain affected by the disease is also responsible for creativity.
Why female Alzheimer’s patients rapidly decline
Hebrew University researchers have discovered that women lose certain mitochondria (maternally inherited) RNA molecules in their brains much faster than men. This adversely affects the neurotransmitter that plays a role in memory, learning, attention, and more.
Preventing strokes from CAD
Israel’s InspireMD (see previously) has just completed the first in-human trial of its CGuard Prime stent that opens blocked Carotid Arteries and traps dangerous emboli released. Carotid Artery Disease (CAD) can stop blood flow to the brain and cause a stroke.